Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice

Cited by (290)

Items 201–290 of 290

1. The future of therapy for alcoholic hepatitis – Beyond corticosteroids
   Nikhil Vergis, Stephen R. Atkinson, Mark R. Thursz · 2019 · Journal of Hepatology
2. Regulation of intestinal senescence during cholestatic liver disease modulates barrier function and liver disease progression
   Mar Moreno‐Gonzalez, Katherine Hampton, Paula Santa Bárbara Ruiz, Gemma Beasy, Falk S. P. Nagies, Aimée Parker, James Lazenby, Caitlin Bone, Ane Alava-Arteaga, Meha P. Patel et al. · 2024 · JHEP Reports
3. Ramulus Mori (Sangzhi) alkaloids ameliorate high-fat diet induced obesity in rats by modulating gut microbiota and bile acid metabolism
   Xin Chun Shang, Yu Fu, Ying Wang, Shuxun Yan · 2024 · Frontiers in Endocrinology
4. Characteristics and Clinical Significance of Gut Microbiota in Patients With Epstein‐Barr Virus‐Associated Liver Dysfunction
   Yi Zhan, Yu Fu, Hanqi Dai, Haihong Gao, Shanshan Huang, Huijuan Chen, Jianxin Xu · 2025 · Microbiology and Immunology
5. Integrated control of leukocyte compartments as a feature of adaptive physiology
   Nikolai Jaschke, Andrew Wang · 2025 · Immunity
6. NLRP3 and Gut–Liver Axis: New Possibility for the Treatment of Alcohol‐Associated Liver Disease
   Lu Dong, Haotian Zhang, Yanyu Kang, Fei Wang, Ting Bai, Yong Yang · 2025 · Journal of Gastroenterology and Hepatology
7. The gut microbiota: A new perspective for tertiary prevention of hepatobiliary and gallbladder diseases
   Xiaoyu Huang, Yi Yang, Xueli Li, Xiaoya Zhu, Dan Lin, Yueran Ma, Min Zhou, Xiangyi Cui, Bingyu Zhang, Dongmei Dang et al. · 2023 · Frontiers in Nutrition
8. Genome-Assisted Probiotic Characterization and Application of Lactiplantibacillus plantarum 18 as a Candidate Probiotic for Laying Hen Production
   Guoqing Zhang, Ning Yang, Zhongyuan Liu, Xinyu Chen, Mengjiao Li, Tongyu Fu, Donghong Zhang, Cuiqing Zhao · 2023 · Microorganisms
9. The liver-gut axis perspective: Exploring the pathogenesis of fatty liver
   Zonghui Yang, Jinbao Zhang, Xiaona Liu, Honggang Chen, Haijing Duan, Qian Wang, Wenlong Zhao, Ling Jin · 2025 · European Journal of Pharmacology
10. Exploration of new therapeutic targets for viral hepatic fibrosis, alcoholic hepatic fibrosis, and non-alcoholic hepatic fibrosis
    Xiaoling Wang, Ying Wang, Xuewei Li, Shuo Qin, Jun Xu, Jun Xie · 2022 · Annals of Translational Medicine
11. Molecular Pathways Governing the Termination of Liver Regeneration
    Lianne R. de Haan, Rowan F. van Golen, Michal Heger · 2024 · Pharmacological Reviews
12. Protective Effects of Methoxsalen Supplementation on Chronic Alcohol-induced Osteopenia and Steatosis in Rats
    Ju Ri Ham, Ra‐Yeong Choi, Hae-In Lee, Mi‐Kyung Lee · 2020 · Molecules
13. Fexaramine as the intestine-specific farnesoid X receptor agonist: A promising agent to treat obesity and metabolic disorders
    Anna Maria Dąbrowska, Jarosław Dudka · 2025 · Drug Discovery Today
14. Association of the dietary index for gut microbiota and dietary inflammation index with metabolic dysfunction-associated steatotic liver disease and metabolic alcohol-associated liver disease
    Wenhao Wu, Zebin Hou · 2025 · Frontiers in Immunology
15. Gut–liver axis dysregulation and microbial dysbiosis in invasive liver abscess: a narrative review
    Xiaoshuai Bai, Zhen Wang, Kai Guo, Ping Zhou, Lei Shi · 2025 · Frontiers in Immunology
16. Identification of a novel FOXO3 agonist that protects against alcohol induced liver injury
    Jinying Peng, Gaoshuang Liang, Yaqi Li, Siyu Mao, Chen Zhang, Ying Wang, Zhuan Li · 2024 · Biochemical and Biophysical Research Communications
17. Molecular targets of PXR-dependent ethanol-induced hepatotoxicity in female mice
    Sora Choi, Malvin Ofosu‐Boateng, Sarah Kim, Daniel Okwudili Nnamani, Mia Mahmoud, Prince Neequaye, Lidya H Gebreyesus, Elizabeth Twum, Frank J. Gonzalez, Julia Yue Cui et al. · 2024 · Biochemical Pharmacology
18. Intestinal Microbiotas and Alcoholic Hepatitis: Pathogenesis and Therapeutic Value
    Jiazhen Zheng, Ziyi Li, Hengyi Xu · 2023 · International Journal of Molecular Sciences
19. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INT ‐787, a Novel Farnesoid X Receptor Agonist, in Healthy Volunteers: A Phase 1 Trial
    Thomas A. Capozza, Jennifer Burkey, Jeroen Van De Wetering, Reinhold Kerb, Jennifer Callahan, Ludmila A. Kryzhanovskaya, Mary Erickson · 2025 · Clinical and Translational Science
20. Probiotic VSL#3 alleviates intrahepatic cholestasis of pregnancy by upregulating farnesoid X receptor-fibroblast growth factor 15 through regulation of the gut microbiota
    Zhihua Zeng, Hua Li, Weitao Yang, Li Li, Ping Ni, Qiuling Chen, Wenjuan Zhou, Jing Pian Peng, Le Huang · 2025 · Journal of Reproductive Immunology
21. Cyclic Nucleotide Phosphodiesterases in Alcohol Use Disorders: Involving Gut Microbiota
    Xueqin Hou, Cuiping Rong, Qiwei Zhang, Shuangshuang Song, Yi-Fan Cong, Han‐Ting Zhang · 2022 · The International Journal of Neuropsychopharmacology
22. Hyocholic acid: A novel therapeutic strategy for metabolic syndrome
    Bohan Rong, Qian Zhang, Xiaohan Zhang, Na Zhang, Zhentong Shen, Yu Pang, Xu Kevin Lin, Di Liu, Xiuqin Yang · 2024 · The Innovation Life
23. Regulatory effect of Chinese Baijiu on gut microbiota and host metabolism
    Cheng Fang, Bowen Wang, Yehui Han, Xiaojiao Zheng, Wei Ping Jia, Jinyuan Sun, Yan Xu · 2025 · Food Research International
24. Multi-omics analysis reveals the mechanism of Cistanche deserticola against alcoholic liver disease via bile salt hydrolase and SCD1
    Shuo Yuan, Peng Gao, Jun Lei, Jiaxu Sun, Xinlan Fang, Pengfei Tu, Yingyuan Lu, Yong Jiang · 2025 · Journal of Ethnopharmacology
25. Dual Mechanisms of Raffinose in Attenuating Alcoholic Liver Injury: Gut Microbiota Modulation and Microbiota-Independent Bile Acid Pool Reprogramming
    Lili Hu, Tianchi Duan, Yuhang Hao, Chennan Wang, Lu Wang, Peng Xu, Xiao Yang, Xingbin Yang, Ting Li · 2025 · Journal of Agricultural and Food Chemistry
26. Synergistic effects of ferulic acid and wogonin on cholestatic liver injury via gut microbiota modulation
    Xin Luo, Ting Mao, Xi Wang, Peng Cheng, Mingyuan Liu, Ruizhi Tao, Feihui Wang, Li Zhao, Yunlong Shan, Yin Lu et al. · 2025 · npj Biofilms and Microbiomes
27. Probiotic-derived extracellular vesicles attenuate cholestatic liver damage via gut-liver axis
    Xianjiao Liu, Yanyan Wang, Andrea Abreo Medina, Dandan Liu, Jinyan Liu, Wenxuan Tang, Mengmeng Wang, Xingxiang Chen, Kehe Huang, Min Liu et al. · 2026 · Pharmacological Research
28. Intestinal Microbes, Metabolites, and Hormones in Alcohol-Associated Liver Disease
    Ruimeng Wang, Fang Ma, Dou Yin, Hua Wang, Xiaohui Wei · 2025 · Seminars in Liver Disease
29. Effects of intestine-specific deletion of fibroblast growth factor 15 on alcoholic liver disease development in mice
    B. Kong, Ming-Xing Huang, Rulaiha E. Taylor, D. Rizzolo, Katherine Otersen, Grace L. Guo · 2022 · Liver Research
30. Gehua Jiejiu Dizhi decoction ameliorates alcoholic fatty liver in mice by regulating lipid and bile acid metabolism and with exertion of antioxidant stress based on 4DLabel-free quantitative proteomic study.
    Han Min, Y I Xu, You Shaowei, W U Xueli, Wang Shuoshi, H E Diancheng · 2024 · PubMed Central
31. Gut Bacteria Provide Genetic and Molecular Reporter Systems to Identify Specific Diseases
    Leon M. T. Dicks · 2024 · International Journal of Molecular Sciences
32. Finding fibroblast growth factor 19 during cholestasis: Does x mark the spot?
    Lianne R. de Haan, Rowan F. van Golen · 2018 · Journal of Hepatology
33. Sub-chronic realgar exposure causes liver inflammatory injury in mice by inducing bile acid-mediated NLRP3 inflammasome activation through down-regulation of ileal FXR
    Guangyan Li, T Wang, Yixuan Xie, Lu He, Huan Liu, Hongying Chen, Hong Jiang, Taoguang Huo · 2025 · Journal of Ethnopharmacology
34. The role of FGF19–FGFR4 signaling pathway in liver health and disease: Guardian or destroyer
    Zhangfan Wu, Yijun Wang, Jiaqian Zhang, Siwen Li, Junjie Wen, Dian Hu, Junqing Jiang, Zerui Zhang, Xiangyuan Luo, Limin Xia · 2025 · Genes & Diseases
35. Impact of alcohol on gut microbial metabolism and the gut-liver-brain axis
    Linton Freund, Berenice Ramirez Leal, Cynthia L. Hsu · 2026 · Alcohol
36. Cholestasis in Alcohol-Associated Liver Disease
    Shengmin Yan, X. Yin · 2025 · American Journal of Pathology
37. Role of FGF15 in Hepatic Surgery in the Presence of Tumorigenesis: Dr. Jekyll or Mr. Hyde?
    Albert Caballeria-Casals, Marc Micó-Carnero, Carlos Rojano-Alfonso, Cristina Maroto-Serrat, Araní Casillas-Ramírez, Ana I. Álvarez‐Mercado, Jordi Gracia‐Sancho, Carmen Peralta · 2021 · Cells
38. Synthesis of TUDCA from chicken bile: immobilized dual-enzymatic system for producing artificial bear bile substitute
    Tang Shijing, Pan Yinping, Qiong Yang, Lou Deshuai, Zhu Liancai, Tan Jun, Liu Shaoyong, Bochu Wang · 2024 · Microbial Cell Factories
39. Etracellular vesicles from lactobacillus rhamnosus GG protect against alcohol-induced liver injury through suppression of intestinal MIR 194 and subsequent activation of FXR in mice.
    Mengwei Jiang · 2022
40. Dietary Gallic Acid Alleviates Hypercholesterolemia in High‐Fat‐Diet‐Fed Mice by Modulating Cholesterol and Bile Acid Metabolism
    Yu Wang, Juan Sun, Lamei Xue, Yujie Sun, Kuiliang Zhang, Mingcong Fan, Haifeng Qian, Yan Li, Li Wang · 2025 · Molecular Nutrition & Food Research
41. Research progress on the prevention and treatment of diseases with traditional Chinese medicine: A focus on BA receptors
    Xin Guo, Mei Zhang, Mengjun Xie · 2025 · The Journal of Steroid Biochemistry and Molecular Biology
42. Alleviation of high-fat diet-induced lipid metabolism disorders: role of quinoa peptides in reducing high-activity BSH-producing gut microbiota abundance and modulating BA-FXR/TGR5 signaling
    Yiju Li, Yuyu Zhang, Tianqi Liu, Yuanrong Tuo, Yu Zhang, Haixi You, Siwang Peng, Tianliang Wu, Ting Cai, Zhiqing Lin et al. · 2026 · Journal of Advanced Research
43. Safflower Polysaccharides Target FXR to Regulate Intestinal Flora and Metabolic Disorders, Affecting FGFR4 / FGF15 to Improve Alcoholic Liver Fibrosis in Mice
    Yuanchuang Wang, Zijun Zhao, Q. Y. Li, Lishang Dai, Kaiyue Zhang, YaTing Lu, Mengwei Jia, Zilin Song, Min Liu, Shenghui Chu · 2026 · Phytotherapy Research
44. Pharmacology of NASH
    Somaya A. M. Albhaisi, Arun Jayant Sanyal · 2021 · Elsevier eBooks
45. Therapeutic Potential of Danyankang Capsule in High-Fat Diet-Induced Cholelithiasis and Its Impact on Liver FXR Signaling and Gut Microbiota
    Lin Zhou, Chu-Ling Zhang, Kun Jiang, Hongyu Cheng, Wen-Wen Xiong, Ji‐Xiao Zhu · 2024 · Biological and Pharmaceutical Bulletin
46. Cross‐sectional and Mendelian randomization study of fibroblast growth factor 19 reveals causal associations with metabolic diseases
    Yan Li, Changyong Dai, Haiqing Yang, Huang Zeng, Yuhua Ruan, Mingjia Dai, Jungui Hao, Liping Wang, Xuebing Yan, Fang Ji · 2024 · Journal of Gastroenterology and Hepatology
47. Research Advances in the Association Between Gut Microbiota and Hepatic Alveolar Echinococcosis: A Review Study
    Haihong Zhu, Shi Zuo, Jian Wang · 2025 · Hepatitis Monthly
48. Microbiome modulation as a therapeutic strategy for alcohol-induced gut dysbiosis and associated disorders
    Loushambam Samananda Singh, Lautambam Sanathoiba Singha, Waikhom Somraj Singh, Yungkham Rajeevkumar Singh, Gansyamie Koknal Marak · 2025 · Antonie van Leeuwenhoek
49. Selective Depletion of Gut Gram-Negative Bacteria Attenuates Alcohol Binge-Induced Cardiovascular Dysfunction by Lowering Cardiac Anandamide Levels
    Sarah E. Cohen, Meagan E. Donovan, Davin J. Gardner, Danielle O. Sambo, Seray B. Karagoz, Reşat Çınar, David A Goldman, Jason D. Gardner, Pál Pacher, János Pálóczi · 2025 · American Journal Of Pathology
50. Fucoidan ameliorates alcoholic liver fibrosis through modulation of the gut-bile acid-liver metabolic axis
    Yexin Pu, Zijian Zhou, Haoran Xue, Yanxia Ma, Nan Zhang, Guifa Wang, Shuo Zang, Ziwei Liu, Meilan Xue, Hui Liang · 2026 · Food Bioscience
51. The gut-liver-immune axis: structural basis, cellular architecture, molecular mediators, and disease-specific manifestations
    Sang Jun Yoon, Jung A Eom, Ki Tae Suk · 2026 · Frontiers in Immunology
52. Recent advances in understanding cross-talk between Bile Acids and Gut Microbiota
    Feng CC, Zhang AH, JH Miao, Sun H, Yanfei Han, Yan Gl Gl, Wu FF, Xuejun Wang · 2018 · Open Journal of Proteomics and Genomics
53. The Role of Nutrition in the Pathogenesis and Treatment of Alcohol-Related Liver Disease
    Haripriya Maddur, Vijay H. Shah · 2020 · Current Hepatology Reports
54. La acuicultura en México, bases conceptuales y principios
    Martha Rodríguez Gutiérrez, Catalina Maldonado Jiménez · 1996 · Oceanologia
55. Direct Implications between Prenatal Alcohol Consumption and Gut Microbiome in the Neurodevelopment of Mice Offspring – Focusing On Foetal Alcoholic Spectrum Disorders
    Cristiano Pedroso-Roussado, Fergus Michael Guppy, Lucas D. Bowler, João Inácio · 2022 · Preprints.org
56. The gut microbiome and gut-liver axis in NAFLD
    Chuanyong Guo, Jie Ji, Jianye Wu, Liwei Wu, Jiao Feng, Jingjing Li, Qiang Yu, Weiqi Dai, Yan Li, Yuanyuan Zheng · 2024
57. Current Understanding of Alcoholic Liver Disease: A prevalent "hidden" disease of increasing clinical importance
    Hidekazu Tsukamoto · 2018 · Kanzo
58. Effects of Growth Factors and Cytokines on the Liver Regeneration Phase of DILI
    亚利 魏 · 2022 · Advances in Clinical Medicine
59. Alcohol-related liver diseases
    Hua Wang · 2023 · Chinese Science Bulletin (Chinese Version)
60. A Sustainable Approach Towards Prevention and Treatment of Hepatic and Other Disorders Associated with Alcohol Consumption
    Zulfa Nooreen, Ankita Shukla, Anuja Shukla, Priyanka Verma · 2023 · Current Drug Therapy
61. Microbiota and Alcohol-Related Liver Disease
    Alina Popescu, Felix Bende · 2023 · Springer eBooks
62. Modern Therapeutic Approaches to the Treatment of Alcoholic Hepatitis
    A.A. Usanova, Fadi Kuzma, Elvira K. Novikova, Сергутова Наталья Петровна · 2024 · Актуальные проблемы медицины
63. Overexpression of microRNA-126 in Adipose-Derived Mesenchymal Stem Cells Alleviate the Alcoholic Liver Injury
    Qianjing Du, Tongtong Pan, Yuanhang Xia, Weijian Yang, Shiyi Zeng, Ru Jin, Rongrong Shao, Xiaozhi Jin, Xiaodong Wang, Yongping Chen et al. · 2024 · Research Square
64. New Approaches to Alcohol-Associated Hepatitis
    Rohit Wagh, Saggere Muralikrishna Shasthry, Shiv Kumar Sarin · 2025 · Clinics in Liver Disease
65. Wolfberry prevented liver damage caused by anti-tuberculosis drugs associated with the YAP1/FXR pathway through gut microbiota
    Dan Wang, Yajun Xiong, Zhihan Liu, Xiaoyong Song, Jiaojiao Liu, Yanli Gong, Zhuanzhuan Li, Xinli Shi · 2025 · Frontiers in Microbiology
66. Blautia coccoides Alleviates Acute Pancreatitis via Bile Salt Hydrolase-mediated Deoxycholic Acid Production and Farnesoid X Receptor Signaling
    Yang Fu, Binqiang Xu, Wenfei Qin, Wei Xiao, Huizhen Huang, Jia Hu, Mengyan Cui, Qixiang Mei, Junjie Fan, Chunlan Huang et al. · 2026 · Cellular and Molecular Gastroenterology and Hepatology
67. Modulating Bile Acid Metabolism: The Role of Blautia coccoides in Acute Pancreatitis
    Guotao Lu · 2026 · Cellular and Molecular Gastroenterology and Hepatology
68. Exploring the mechanism of Jianpi Guchang recipe and its compound: Inhibition liver metastasis in colorectal carcinoma through regulation of the bile acid-FXR-FGF19 axis
    Cunya Li, Pantong Wu, Zhonghua Wu, Jian Chen, Zhiying Wang, Zhixian Zhong, Yi Zhong, Shujuan Fu · 2026 · Advances in Cancer Biology - Metastasis
69. Chaihu-Shugan San ameliorates perimenopausal obesity with depression by coordinately targeting hepatic PGC-1α/CYP8B1/PPARγ signaling and gut barrier integrity
    Qiliang Chen, Jian Liu, Junqiao Wang, Ting Yin, Yedi Wu, Tianpeng Zhang, Fangjun Yu · 2026 · Journal of Ethnopharmacology
70. Vinegar-processed Paeonia lactiflora Pall. ameliorates alcoholic liver disease through the modulation of gut microbiota and FXR–FGF15 gut–liver axis
    Xi-yu Zhang, Xiang-xiang Liu, Elsa Easter Justine, Zhi-hui Xi, Menglu Li, Tong-sheng Wang, Chuanshan Jin, Wei Zhang, Xiao-jie Mi · 2026 · Journal of Ethnopharmacology
71. Le microbiote intestinal comme cible thérapeutique dans la maladie alcoolique du foie : implication des acides biliaires et de la pectine
    Dragos Marius Ciocan · 2018 · theses.fr (ABES)
72. Étude du lien entre maladie alcoolique du foie, microbiote intestinal et acides biliaires : rôles spécifiques de la pectine et du récepteur aux acides biliaires TGR5
    Madeleine Spatz · 2018
73. La nécroptose : une nouvelle cible thérapeutique dans la stéatohépatite non-alcoolique
    Amine Majdi · 2020 · theses.fr (ABES)
74. Rôle du récepteur nucléaire Farnesoid X Receptor intestinal dans la fonction immune de l’intestin dans le contexte physiopathologique de la stéatohépatite non alcoolique
    Margaux Nawrot · 2021 · theses.fr (ABES)
75. Regulation of bile acids homeostasis: a feasible and versatile way to treat or diagnose liver disorders
    Qianqian Wu, Le-Ying Gao, Huiyi Feng, Hao-Lin Liu, Hui Gao, Wei Peng, Nan Li · 2026 · Frontiers in Nutrition
76. Intestinal Sirtuin 1 Controls Liver Regeneration via Regulating the Intestinal Farnesoid X Receptor/Fibroblast Growth Factor 15 Axis in Mice
    Sian Seaman, Paula Ruiz, Vinícius Dias Nirello, Laura Martin-Castilla, Pablo Elizalde-Garcia, Adriana Vega-Zuza, Lucia Vegas-Petrina, Cristina Lumbreras-Perales, Mark Philo, Mar Moreno‐Gonzalez et al. · 2026 · Cellular and Molecular Gastroenterology and Hepatology
77. Role of gut microbiota in dioxin-induced hepatotoxicity and diffuse liver pathology under chronic exposure
    Vera Yu. Gatsura, L. E. Deryagina, Aleksandr Olegovich Pyatibrat, Vladimir L. Reiniuk, Виктор Константинович Козлов, Elena D. Pyatibrat, Виктория Валерьевна Стельмах, Valery V. Romanov · 2026 · Экология человека
78. Lactobacillus reuteri targets farnesoid X receptor-dependent bile acid homeostasis to ameliorate alcoholic liver disease
    Shuo Yuan, Yuhua Liu, Peng Gao, Jiaxu Sun, Yuanshi Wang, Zhiyong Du, Jun Lei, Jiaxin Hong, Fang Xh, Pengfei Tu et al. · 2026 · The ISME Journal
79. Dendrobium nobile Lindl. alleviates acute alcoholic liver injury in mice by modulating bile acid metabolism via the enterohepatic circulation
    Di Wu, Qingping Yang, J Y Ye, Xuelan Chen, Xingdong Wu, Lin Qin, Lü Yc, Daopeng Tan, Yu-qi He · 2026 · Journal of Ethnopharmacology
80. Spatiotemporal dynamics of bile acid profiles in broilers from hatch to market age
    Sunlin Luo, Ruiqi Tan, Qiaomin Duan, Wenjun He, Ying Liu, Yiqiang Chen · 2026 · Poultry Science
81. β ‐Nicotinamide mononucleotide reduces aflatoxin B1 induced liver injury via the gut microbiota‐bile acid‐farnesoid X receptor (FXR/NR1H4) axis
    Yanyan Wang, Andrea Abreo Medina, Xianjiao Liu, Yongwang Liu, Wenqi Du, Yuhan Wang, Jinxiang Yang, 蒋天雪, X S Chen, Kehe Huang et al. · 2026 · British Journal of Pharmacology
82. MASLD: Spatial Mechanisms and New Therapeutics
    Christian Stoess, Janset Onyuru, Yanzhu Hu, Yuan Jiang, Zhengyi Xin, Aryan Panchal, Phillipp Hartmann · 2026 · Biomolecules
83. Notoginsenoside R1 alleviates cholestatic liver fibrosis through modulation of the intestinal FXR-FGF15 axis and bile acid homeostasis
    Min Yang, 马巧莲, Bairong Yang, Jie Li, Weiyu Chang, Xiuming Cui, Ben Niu, Feng Ge · 2026 · Biochemical Pharmacology
84. The Polysaccharides from Balanophora harlandii Hook. Alleviated Alcoholic Steatohepatitis via Suppressing Bile Acid Synthesis Mediated by Intestinal FXR Activation
    Li Xiao, Jingjing Chen, Wenyan Zhong, Fan Peng, Chengfu Yuan · 2026 · Nutrients
85. Ethanol exposure is associated with spatial and taxon-specific gut microbiota remodeling characterized by ecological adaptation rather than broad activation of microbial ethanol metabolism
    Mingliang Li, Jieqi Mao, Shuangping Liu, Haojie Yu, Hui Qin, Xiaogang Liu, Rongkun Tu, Sheng Chen, Ziming Liu, Suyi Zhang et al. · 2026 · Gut Microbes
86. Canonical and Non-Canonical Regulators of Lipid Metabolism in the Liver and the “Liver–Other Organs” Axes
    Stanislav Nikolaevich Kotlyarov, Анна Анатольевна Котлярова, Roberto Catanzaro, Francesco Marotta · 2026 · International Journal of Molecular Sciences
87. Gut microbiota-mediated FGF metabolic axis in the pathogenesis, prevention and treatment of various diseases
    Xianxi Ye, Zhuofan LU, Weiru ZHANG, Xuelian LIU, Hong ZHENG · 2026 · Journal of Zhejiang University (Medical Sciences)
88. Exploring the impacts of tetracycline on gut microbiota–bile acid homeostasis using metagenomics, metabolomics and molecular docking
    Wanzhu Li, Mian Wei, Hongyuan Wang · 2026 · Journal of Environmental Sciences
89. Ferroptosis in alcohol-associated liver disease: from mechanisms to food-derived interventions
    Hangjie Fu, Wenxia Li, Xiaoxue Nan, 陈慧豪, Bin Ding, Songtao Li · 2026 · Journal of Functional Foods
90. Food-Grade Silicon Dioxide Nanoparticles Disrupt the Microbiota-Associated Gut–Liver Axis and FXR-Related Bile Acid Homeostasis in Mice
    Ziwen Qü, Panpan Wang, Shuanglei Zhang, Jiaqi Wang, Yanbo Wang, Yongning Wu, Guoliang Li · 2026 · Journal of Agricultural and Food Chemistry